Pyxis Oncology
PYXS
PYXS
92 hedge funds and large institutions have $102M invested in Pyxis Oncology in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
10% more capital invested
Capital invested by funds: $93.1M → $102M (+$9.25M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.84% less ownership
Funds ownership: 47.77% → 46.93% (-0.84%)
Holders
92
Holding in Top 10
2
Calls
$2.02M
Puts
$279K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.87M | |
| 3 | +$1.52M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.37M |
Top Sellers
| 1 | -$8.58M | |
| 2 | -$2.59M | |
| 3 | -$1.6M | |
| 4 |
SC
Stempoint Capital
New York
|
-$1.29M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$863K |